• Diagnosis​ Info ​and​ ​General​ ​Questions

  LentiGlobin Gene Therapy Continues to Show Promising Results in SCD, Updated Trial Data Shows

  Posted by Sickle Cell Forum Administrator on March 24, 2021 at 9:00 am

  

  Bluebird Bio’s LentiGlobin continues to show promising results in SCD patients participating in a Phase 1/2 HGB-206 clinical trial, new data shows. Read more here.

  What did you think of this article?

  Sickle Cell Forum Administrator replied 5 years, 9 months ago 0 Member · 0 Replies

  • Diagnosis
  • Research
• 0 Replies

Log In to Reply